-
1
المؤلفون: Brent C. Opmeer, Katja N. Gaarenstroom, Mirjam J. A. Engelen, M. Caroline Vos, Christiana A. Naaktgeboren, Kees G. Gerestein, Patrick M.M. Bossuyt, Ben W.J. Mol, Anje M. Spijkerboer, Guus Fons, Toon Van Gorp, Petra L.M. Zusterzeel, Henk W.R. Schreuder, Hannah S. van Meurs, Eltjo M.J. Schutter, Roelien van de Vrie, Henk G. ter Brugge, Gemma G. Kenter, Maarten van Haaften, Ward Hofhuis, Erik A. Boss, Marrije R. Buist, Johanna M.A. Pijnenborg, Henriette J. G. Arts, Marianne J. Rutten
المساهمون: Targeted Gynaecologic Oncology (TARGON), CCA -Cancer Center Amsterdam, Obstetrics and Gynaecology, CCA - Cancer Treatment and Quality of Life, Graduate School, APH - Methodology, Clinical Research Unit, ACS - Amsterdam Cardiovascular Sciences, Other Research, Radiology and Nuclear Medicine, APH - Personalized Medicine, 10 Public Health & Methodologie, APH - Quality of Care, ARD - Amsterdam Reproduction and Development, Obstetrie & Gynaecologie, MUMC+: MA Medische Staf Obstetrie Gynaecologie (9), RS: GROW - R2 - Basic and Translational Cancer Biology, Gynaecologie en Obstetrie
المصدر: Journal of Clinical Oncology, 35(6), 613-621. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 35(6), 613. American Society of Clinical Oncology
Journal of clinical oncology, 35(6):6, 613-621. American Society of Clinical Oncology
Journal of Clinical Oncology, 35, 6, pp. 613-621
Journal of Clinical Oncology, 35(6), 613
Journal of Clinical Oncology, 35, 613-621
Journal of Clinical Oncology, 35(6), 613-621. American Society of Clinical Oncologyمصطلحات موضوعية: EXTERNAL VALIDATION, Cancer Research, Neoplasm, Residual, medicine.medical_treatment, Carcinoma, Ovarian Epithelial, law.invention, NEOADJUVANT CHEMOTHERAPY, 0302 clinical medicine, Randomized controlled trial, law, Laparotomy, Neoplasms, Glandular and Epithelial, Laparoscopy, Ovarian Neoplasms, RISK, 030219 obstetrics & reproductive medicine, medicine.diagnostic_test, Middle Aged, INTERVAL DEBULKING SURGERY, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], Multicenter Study, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Predictive value of tests, Randomized Controlled Trial, SURGICAL CYTOREDUCTION, Female, medicine.medical_specialty, CARCINOMA, ADNEX MODEL, Disease-Free Survival, 03 medical and health sciences, Predictive Value of Tests, SCORE, Journal Article, medicine, Carcinoma, Humans, Aged, Neoplasm Staging, STAGE III/IV OVARIAN, Chemotherapy, business.industry, General surgery, medicine.disease, Surgery, Relative risk, Ovarian cancer, business, ABDOMINAL-WALL METASTASES
وصف الملف: image/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88afffec900de1bc3a3271a3325055c3
https://doi.org/10.1200/jco.2016.69.2962 -
2
المؤلفون: Maarten van Haaften, Marrije R. Buist, Marianne J. Rutten, Ward Hofhuis, Katja N. Gaarenstroom, Erik A. Boss, Brent C. Opmeer, Eltjo M.J. Schutter, Mirjam J. A. Engelen, Ben W.J. Mol, Kees G. Gerestein, Hannah S. van Meurs, Henriette J. G. Arts, Henk W.R. Schreuder, Gemma G. Kenter, M. Caroline Vos, Johanna M.A. Pijnenborg, Henk G. ter Brugge, Roelien van de Vrie, Christiana A. Naaktgeboren, Patrick M.M. Bossuyt, Toon Van Gorp, Petra L.M. Zusterzeel
المساهمون: CCA - Cancer Treatment and Quality of Life, Graduate School, Obstetrics and Gynaecology, Cancer Center Amsterdam, APH - Methodology, Clinical Research Unit, APH - Personalized Medicine, Epidemiology and Data Science, APH - Quality of Care, Amsterdam Reproduction & Development (AR&D), Targeted Gynaecologic Oncology (TARGON), Obstetrie & Gynaecologie, MUMC+: MA Medische Staf Obstetrie Gynaecologie (9), RS: GROW - R2 - Basic and Translational Cancer Biology, Gynaecologie en Obstetrie, Obstetrics and gynaecology, CCA - Cancer Treatment and quality of life
المصدر: van de Vrie, R, van Meurs, H S, Rutten, M J, Naaktgeboren, C A, Opmeer, B C, Gaarenstroom, K N, van Gorp, T, Ter Brugge, H G, Hofhuis, W, Schreuder, H W R, Arts, H J G, Zusterzeel, P L M, Pijnenborg, J M A, van Haaften, M, Engelen, M J A, Boss, E A, Vos, M C, Gerestein, K G, Schutter, E M J, Kenter, G G, Bossuyt, P M M, Mol, B W & Buist, M R 2017, ' Cost-effectiveness of laparoscopy as diagnostic tool before primary cytoreductive surgery in ovarian cancer ', Gynecologic Oncology, vol. 146, no. 3, pp. 449-456 . https://doi.org/10.1016/j.ygyno.2017.06.019
Gynecologic Oncology, 146, 3, pp. 449-456
Gynecologic oncology, 146(3), 449-456. Academic Press Inc.
Gynecologic Oncology, 146, 449-456
Gynecologic Oncology, 146(3), 449-456
Gynecologic Oncology, 146(3), 449-456. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic Oncology, 146(3), 449. Academic Press Inc.
Gynecologic Oncology, 146(3), 449-456. Elsevier Science
Gynecologic Oncology, 146(3), 449-456. Academic Press Inc.مصطلحات موضوعية: Cost effectiveness, PREDICTION, medicine.medical_treatment, Cost-Benefit Analysis, law.invention, NEOADJUVANT CHEMOTHERAPY, 0302 clinical medicine, Obstetrics and gynaecology, Randomized controlled trial, Quality of life, law, QUALITY-OF-LIFE, Health care, Obstetrics and Gynaecology, Cytoreductive surgery, 030212 general & internal medicine, Laparoscopy, Neoadjuvant therapy, Ovarian Neoplasms, medicine.diagnostic_test, Obstetrics and Gynecology, Cytoreduction Surgical Procedures, Health Care Costs, Middle Aged, Neoadjuvant Therapy, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], TRIALS, Oncology, Diagnostic Techniques, Surgical, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, Quality-Adjusted Life Years, Medical Futility, medicine.medical_specialty, Diagnostic laparoscopy, 03 medical and health sciences, Ovarian cancer, medicine, Journal Article, Humans, PRIMARY DEBULKING SURGERY, Neoplasm Staging, business.industry, General surgery, ONCOLOGY, PHASE-III, Quality-adjusted life year, Cost-effectiveness, business
وصف الملف: image/pdf; application/pdf